Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection-Reference-Cited by-同舟云学术

Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection

Published:2023-05-10 Issue:2 Volume:58 Page:91-98
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Sadeghi Alireza¹,Sadeghi Somayeh²,Peikar Mohammad Saleh¹,Yazdi Maryam³,Sharifi Mehran¹⁴,Ghafel Safie⁵,Khorvash Farzin⁶,Ataei Behrooz²,Safavi Mohammad Reza⁷,Nasri Elahe²

Affiliation:

1. Department of Internal Medicine, School of Medicine, Isfahan, Iran

2. Infectious Diseases and Tropical Medicine Research Center, Isfahan, Iran

3. Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan, Iran

4. Cancer Prevention Research Center Seyed Al-Shohada Hospital, Isfahan, Iran

5. Mycology Reference Laboratory, Research Core Facilities Laboratory, Isfahan, Iran

6. Acquired Immunodeficiency Research Center, Isfahan, Iran

7. Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

http://pdf.medrang.co.kr/BR/2023/058/BR2058-02-91.pdf

Reference36 articles.

1. Coronavirus disease 2019 (COVID-19): A literature review

2. On admission hemoglobin and albumin, as the two novel factors associated with thrombosis in COVID-19 pneumonia

3. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

4. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

5. The demographic, clinical, and medical manifestations of pulmonary thromboembolism development in COVID-19

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of immune-modulating agents to regulate hyperinflammation in severe COVID-19; the assessment of tocilizumab use in combination with steroids;2024-02-19

2. Effects of evidence-based clinical practice guidelines for COVID-19 in health care quality improvements. A third systematic review.;F1000Research;2023-11-24

3. Optimizing the use of vilobelimab for the treatment of COVID-19;Expert Opinion on Biological Therapy;2023-07-10